LFMDNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMDP
LifeMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$2.25−0.09 (-3.85%)
Close on Oct 19, 2026
- Market cap
- $107.52M
- P/E (TTM)
- –
- Dividend yield
- –
LifeMD statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Offices & Clinics of Doctors of Medicine companies for comparison
Valuation
| Measure | LifeMD | Industry median |
|---|---|---|
| Market Cap | $108.45M | $1.07B |
| Enterprise Value | $83.31M | $1.35B |
| PS Ratio | 0.66 | 1.63 |
| PB Ratio | 13.61 | 3.19 |
| P/TBV Ratio | 13.96 | 4.88 |
Enterprise value
| Measure | LifeMD | Industry median |
|---|---|---|
| EV / Sales | 0.51 | 1.78 |
Income (trailing twelve months)
| Measure | LifeMD | Industry median |
|---|---|---|
| Revenue | $164.70M | $543.94M |
| Gross Profit | $141.85M | $162.51M |
| Operating Income | -$24.25M | -$1.92M |
| Pretax Income | -$25.38M | -$575.82K |
| Net Income | $201.01K | -$1.32M |
| EBITDA | -$24.25M | -$29.24K |
| EPS (Diluted) | -$0.05 | -$0.02 |
Margins
| Measure | LifeMD | Industry median |
|---|---|---|
| Gross Margin | 86.1% | 32.7% |
| Operating Margin | -14.7% | -4.46% |
| Pretax Margin | -15.4% | 1.47% |
| Profit Margin | 0.12% | -3.18% |
| EBITDA Margin | -14.7% | 2.41% |
| FCF Margin | -6.71% | 3.11% |
Returns
| Measure | LifeMD | Industry median |
|---|---|---|
| Return on Equity (ROE) | 6.50% | 0.49% |
| Return on Assets (ROA) | 0.30% | -3.06% |
| Return on Capital Employed (ROCE) | -182.6% | -2.29% |
Growth
| Measure | LifeMD | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 3.80% | 7.11% |
| FCF Growth (YoY) | -161.6% | -6.04% |
| Revenue Growth (3Y CAGR) | 17.7% | 10.9% |
| Revenue Growth (5Y CAGR) | 39.1% | 13.2% |
Balance sheet
| Measure | LifeMD | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $25.14M | $47.58M |
| Net Cash (Debt) | $25.14M | $217.65K |
| Net Cash Per Share | $0.52 | $0.01 |
| Equity (Book Value) | $7.97M | $189.59M |
| Book Value Per Share | $0.17 | $3.32 |
| Tangible Book Value | $7.77M | $1.72M |
| Working Capital | -$4.52M | $29.77M |
Financial position
| Measure | LifeMD | Industry median |
|---|---|---|
| Current Ratio | 0.90 | 1.41 |
| Quick Ratio | 0.78 | 0.97 |
Cash flow (trailing twelve months)
| Measure | LifeMD | Industry median |
|---|---|---|
| Operating Cash Flow | -$9.91M | $1.28M |
| Capital Expenditures | -$1.15M | -$16.47M |
| Free Cash Flow | -$11.06M | $23.23M |
| FCF Per Share | -$0.23 | $0.37 |
Efficiency
| Measure | LifeMD | Industry median |
|---|---|---|
| Asset Turnover | 2.47 | 0.83 |
| Inventory Turnover | 7.36 | 11.36 |
| Revenue Per Employee | $423.39K | $218.24K |
| Profits Per Employee | $517 | -$5.96K |
| Employee Count | 389 | 897 |
Dividends and yields
| Measure | LifeMD | Industry median |
|---|---|---|
| Earnings Yield | 0.19% | -1.25% |
| FCF Yield | -10.2% | 1.43% |
| Payout Ratio | 1545.3% | 14.1% |
Shares
| Measure | LifeMD | Industry median |
|---|---|---|
| Shares Outstanding | 48,200,800 | 58,609,450 |
| Shares Change (YoY) | 9.49% | 2.64% |
| Shares Change (QoQ) | 0.61% | 0.29% |
| Float | 39,408,000 | 34,865,600 |
| Shares Held by Insiders | 18.2% | 16.6% |
| Shares Held by Institutions | 44.9% | 85.9% |
Scores
| Measure | LifeMD | Industry median |
|---|---|---|
| Altman Z-Score | -3.18 | 1.98 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from LifeMD's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.